Munafa Stock Market Course + Intraday & FNO calls 
Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for NASDAQ stock CRSP Crispr Therapeutics. Dated: 13 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 51.09 and Closed at: 54.83, which is 6.58% of previous session's close. It moved within a range of 51.05 and 55.09
The session was a Bullish session with an average volume of 1843700, which is 52.73% of previous session's volumes.
- There is some positive change in the mid term trend, but its too soon to jump onto conclusions.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Golden cross was found 3 days back on short term averages
Support for tomorrow is 52.94 and resistance for tomorrow is 56.98
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 52.22, 49.62 resistance for tomorrow's hourly charts is 56.26, 57.7
10 Day SMA for Crispr Therapeutics (CRSP) is 49.86 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 48.64 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 51.57 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 53.25 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 56.36 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 48.64 and 200 DMA is at 56.36, while 50 DMA and 100 DMA are at 51.57 and 53.25 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 48.64 and 20 EMA is at 50.34
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Mon Apr | 54.83 | 48.64 | 50.34 |
| 10 Fri Apr | 51.22 | 48.34 | 49.87 |
| 09 Thu Apr | 51.72 | 48.27 | 49.73 |
| 08 Wed Apr | 51.76 | 48.33 | 49.52 |
| 07 Tue Apr | 49.70 | 48.68 | 49.28 |
| 06 Mon Apr | 49.13 | 49.02 | 49.24 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 51.57 and 50 EMA is at 51.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Mon Apr | 54.83 | 51.57 | 51.56 |
| 10 Fri Apr | 51.22 | 51.54 | 51.43 |
| 09 Thu Apr | 51.72 | 51.59 | 51.44 |
| 08 Wed Apr | 51.76 | 51.64 | 51.43 |
| 07 Tue Apr | 49.70 | 51.7 | 51.42 |
| 06 Mon Apr | 49.13 | 51.81 | 51.49 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 53.25 and 100 EMA is at 53.03
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Mon Apr | 54.83 | 53.25 | 53.03 |
| 10 Fri Apr | 51.22 | 53.23 | 52.99 |
| 09 Thu Apr | 51.72 | 53.22 | 53.03 |
| 08 Wed Apr | 51.76 | 53.23 | 53.06 |
| 07 Tue Apr | 49.70 | 53.26 | 53.09 |
| 06 Mon Apr | 49.13 | 53.31 | 53.16 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 56.36 and 200 EMA is at 53.22
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Mon Apr | 54.83 | 56.36 | 53.22 |
| 10 Fri Apr | 51.22 | 56.33 | 53.2 |
| 09 Thu Apr | 51.72 | 56.31 | 53.22 |
| 08 Wed Apr | 51.76 | 56.28 | 53.24 |
| 07 Tue Apr | 49.70 | 56.24 | 53.25 |
| 06 Mon Apr | 49.13 | 56.21 | 53.29 |
Crispr Therapeutics has performed better than Vericel Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Trupanion Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Syndax Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Surgery Partners in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Regeneron Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Prothena Corporation in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Pulse Biosciences in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Natera Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than National Research in short term. Holding Crispr Therapeutics could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 3.39% more returns!
Axsome Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 1.77% more returns!
Capricor Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 0.76% more returns!
Corcept Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 22.19% more returns!
Crispr Therapeutics has performed better than Crinetics Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Dexcom Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Healthcare Services in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Innoviva Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Ionis Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Crispr Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.18 and Crispr Therapeutics CRSP stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
